New Edge Advisors, LLC Moderna, Inc. Transaction History

New Edge Advisors, LLC

$15 Billion
Q3 2024

A detailed history of New Edge Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 1,636 shares of MRNA stock, worth $60,286. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,636

Previous 7,773 78.95%

Holding current value

$60,286

Previous $923,000 88.19%

% of portfolio

0.0%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$63.64 - $125.14 $390,558 - $767,984	-6,137 Reduced 78.95%	1,636 $109,000
Q2 2024 Aug 15, 2024	SELL	$101.21 - $166.61 $584,285 - $961,839	-5,773 Reduced 42.62%	7,773 $923,000
Q1 2024 May 14, 2024	BUY	$85.37 - $115.44 $104,834 - $141,760	1,228 Added 9.97%	13,546 $1.44 Million
Q4 2023 Feb 13, 2024	BUY	$69.51 - $104.43 $429,015 - $644,541	6,172 Added 100.42%	12,318 $1.23 Million
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $52,543 - $69,002	-545 Reduced 8.15%	6,146 $634,000
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $258,211 - $349,794	-2,179 Reduced 24.57%	6,691 $812,000
Q1 2023 May 12, 2023	BUY	$135.66 - $197.02 $78,140 - $113,483	576 Added 6.94%	8,870 $1.36 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $181,121 - $321,361	1,530 Added 22.62%	8,294 $1.49 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $146,052 - $240,200	-1,237 Reduced 15.46%	6,764 $800,000
Q2 2022 Aug 09, 2022	BUY	$117.13 - $176.59 $937,157 - $1.41 Million	8,001 New	8,001 $1.14 Million
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $1.1 Million - $2.05 Million	-8,724 Closed	0 $0
Q4 2021 Feb 17, 2022	SELL	$225.82 - $368.51 $956,121 - $1.56 Million	-4,234 Reduced 32.67%	8,724 $2.22 Million
Q3 2021 Oct 29, 2021	BUY	$221.9 - $484.47 $610,003 - $1.33 Million	2,749 Added 26.93%	12,958 $4.99 Million
Q2 2021 Jul 22, 2021	BUY	$129.91 - $234.98 $1.02 Million - $1.85 Million	7,889 Added 340.04%	10,209 $2.4 Million
Q1 2021 Apr 26, 2021	SELL	$109.18 - $185.98 $33,081 - $56,351	-303 Reduced 11.55%	2,320 $304,000
Q4 2020 Jan 27, 2021	SELL	$65.74 - $169.86 $261,645 - $676,042	-3,980 Reduced 60.28%	2,623 $274,000
Q3 2020 Nov 03, 2020	BUY	$54.34 - $94.85 $358,807 - $626,294	6,603 New	6,603 $467,000

Others Institutions Holding MRNA

# of Institutions

954

Shares Held

241M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.

Account

New Edge Advisors, LLC Moderna, Inc. Transaction History